Literature DB >> 20664452

Jarisch-Herxheimer reaction triggered by group B streptococcus intrapartum antibiotic prophylaxis.

Martha W F Rac1, Laura G Greer, George D Wendel.   

Abstract

BACKGROUND: The Jarisch-Herxheimer reaction is an acute systemic event that can occur during the treatment of spirochetal infections. During pregnancy, it can cause signs and symptoms in both the mother and fetus, including fever, tachycardia, uterine contractions, and fetal heart rate pattern changes. CASE: A pregnant woman with limited prenatal care presented at 34 weeks of gestation in preterm labor with possible genital herpes. She received ampicillin for group B Streptococcus prophylaxis. Subsequently, she experienced subjective fever and late fetal heart rate decelerations prompting repeat cesarean delivery. Postpartum, her genital lesions were diagnosed as secondary syphilis, and her newborn had congenital syphilis.
CONCLUSION: Beta-lactam antibiotics for group B Streptococcus intrapartum prophylaxis can trigger the Jarisch-Herxhemer reaction in patients with undiagnosed syphilis resulting in unanticipated changes in maternal and fetal well-being.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20664452     DOI: 10.1097/AOG.0b013e3181e7d065

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  4 in total

Review 1.  The Jarisch-Herxheimer Reaction After Antibiotic Treatment of Spirochetal Infections: A Review of Recent Cases and Our Understanding of Pathogenesis.

Authors:  Thomas Butler
Journal:  Am J Trop Med Hyg       Date:  2016-10-24       Impact factor: 2.345

2.  'An unusual response of dental sepsis to antibiotics: parallels with the Jarisch-Herxheimer reaction'.

Authors:  Helen Moss; Jonathan Marc Collier; Sophie Collier
Journal:  BMJ Case Rep       Date:  2012-06-14

3.  The role of regulated clinical trials in the development of bacteriophage therapeutics.

Authors:  Helena Mrt Parracho; Ben H Burrowes; Mark C Enright; Malcolm L McConville; David R Harper
Journal:  J Mol Genet Med       Date:  2012-04-23

4.  Phase II trial evaluating the clinical efficacy of cefixime for treatment of active syphilis in non-pregnant women in Brazil (CeBra).

Authors:  Melanie M Taylor; Edna Oliveira Kara; Maria Alix Leite Araujo; Mariangela Freitas Silveira; Angelica Espinosa Miranda; Ivo Castelo Branco Coelho; Maria Luiza Bazzo; Gerson Fernando Mendes Pereira; Silvana Pereira Giozza; Ximena Pamela Díaz Bermudez; Maeve B Mello; Ndema Habib; My Huong Nguyen; Soe Soe Thwin; Nathalie Broutet
Journal:  BMC Infect Dis       Date:  2020-06-10       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.